Little House Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.88M Sell
8,492
-1,169
-12% -$323K 0.42% 64
2026
Q1
$2.85M Buy
9,661
+224
+2% +$66.5K 0.74% 39
2025
Q4
$2.58M Buy
9,437
+1,150
+14% +$312K 0.65% 44
2025
Q3
$2.24M Buy
8,287
+63
+0.8% +$17.1K 0.51% 47
2025
Q2
$2.27M Buy
8,224
+1,765
+27% +$480K 0.57% 49
2025
Q1
$1.71M Buy
+6,459
New +$1.59M 0.47% 56
2021
Q2
– Sell
-16,063
Closed -$3.28M – 151
2021
Q1
$3.28M Buy
+16,063
New +$3.16M 1.16% 31
2020
Q4
– Sell
-3,360
Closed -$562K – 113
2020
Q3
$562K Buy
3,360
+254
+8% +$42.8K 0.47% 60
2020
Q2
$504K Buy
+3,106
New +$557K 0.46% 59

Other funds holding CME

Little House Capital's CME Position: Q2 2026 in Review

Little House Capital reduced its CME Group (CME) stake by 12% in Q2 2026, selling an estimated $323K and leaving 8,492 shares worth $1.88M. The position accounts for 0.42% of the portfolio, ranked #64.

Little House Capital first reported a position in CME in Q2 2020 and has held it in 9 quarters since. The position peaked at $3.28M in Q1 2021. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Little House Capital held 8,492 shares of CME Group worth $1.88M as of Q2 2026.
  • Little House Capital sold 1,169 CME Group shares in Q2 2026, an estimated $323K.
  • CME Group made up 0.42% of Little House Capital's portfolio in Q2 2026, its #64 holding.
  • Little House Capital first reported a position in CME Group in Q2 2020 and has held it in 9 quarters since.
  • Little House Capital's CME Group position peaked at $3.28M in Q1 2021.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Little House Capital's 13F filing for Q2 2026, filed 7 Aug 2026.